Introduction
The dynorphins are important endogenous human pep-tide hormones that act primarily through binding to the -opioid receptor (OPRK) and have roles in pain response, stress and addiction, amongst others. 1 Opioids and their receptors are important components of the peripheral nervous system, but they also accumulate during host stress at sites of inflammation. 2 Coupled with evidence that bacteria activate virulence in response to host stress, 3 these observations suggest that opioids may be recognized by bacteria as signaling molecules. A small molecule OPRK agonist and the peptide hormone dynorphin-A (Dyn-A)
were shown to activate quorum sensing and result in enhanced virulence of the opportunistic pathogen Pseudomonas aeruginosa (PA). 4 PA is one of the most commonly isolated microbes in patients with bloodstream and lung infections in acute care set-tings in Europe, and the leading cause of death in patients with cystic fibrosis. 5 The pathogen is also very challenging to treat due to its high intrinsic resistance to antibiotics and its ability to modulate its behavior in widely different environments and in response to a host. This ability may stem in part from the organism's large number of two-component sensors, its large genome, and its complex quorum sensing networks. 6 In a rodent stress model, Dyn-A was shown to be released in the intestine where it bound to and was taken up by bacteria. 4 A subsequent study showed that PA regulates its response to a small molecule opioid depending on the abundance of nutrients in the environment, integrating multiple inputs in the decision to switch to the costly virulence phenotype. 7 Bacteria have receptors that recognize other host molecules (e.g. interferon- 8 and adrenergic hormones 9 ). However, the putative dynorphin receptor and the majority of the response circuitries mediating bacterial response to opioids are completely unknown ( Figure   1a ). Targeting virulence or manipulating host-microbe or microbe-microbe communications have been put forward as possible non-traditional approaches to tackle the rise of multidrug resistant bacteria. However, the pathways and environmental conditions, such as host stress and interkingdom signaling, that lead to microbial virulence are poorly explored.
Here, we use a chemical biology approach to unravel the mechanism of action of the human opioid peptide Dyn-A in PA. Phenotypic studies first confirm that the virulence-inducing effect of a truncated dynorphin analogue (DYN) is peptide sequence-dependent. We then employ a chemical proteomic approach using DYN-inspired photoaffinity probes to identify the membrane sensor ParS as a putative binding partner of DYN in live bacteria. In-depth global proteomic analyses further define the specific defense response evoked in PA by DYN. Finally, we show that this defense response is abrogated in a mutant lacking ParS, functionally linking peptide binding to ParS with the phenotypic response.
Results

Dynorphin and derivatives induce Pseudomonas virulence
Since PA virulence is known to be highly environment-dependent, we first sought to define the conditions un-der which dynorphin induced a response. Previous work has linked the peptide Dyn-A (dynorphin(1-17)-OH) and the small molecule opioid U50,488 to induction of virulence in PA strain PAO1. 4, 7 We confirmed that in our hands these compounds also induced the production of the blue-green toxin pyocyanin under similar conditions of nutrient limitation, as did a truncated Dyn-A analogue with a C-terminal amide (DYN, dynorphin(1-13)-NH2; Figure   S1 ). The N-terminus of dynorphin is critical for signaling via human opioid receptors and this truncated peptide is equipotent in the human system. 10 However, although they induced a similar response to each other, the two peptides behaved quite differently compared to the small molecule: there was significant growth reduction at higher concentrations of peptide and a corresponding drop-off of pyocyanin production, whereas U50,488 was less toxic to bacteria and only induced pyocyanin at higher concentrations ( Figure S1 ). It is therefore not clear that dynorphin-based peptides and U50,488 have the same phenotype and thus mode of action.
We decided to focus on the endogenous peptide signals, and, given the similar responses of the two peptides, chose the shorter dynorphin analogue, DYN, for synthetic tractability. We used a chemically defined MOPS-buffered succinate medium to optimize the iron and phosphate contents, since these components are important for the virulence responses of PA ( Figure S1 ). 7 Our optimized conditions generated more reproducible data and we observed that DYN (Figure 1b ) induced mild toxicity and production of pyocyanin in a dose-dependent manner ( Figure 1c ).
To establish whether the sequence of DYN is important for the observed phenotype, we tested a sequence-scrambled peptide (SCR) and a charge-control peptide (CC), which has a different composition but is still highly basic (Figure 1b) . The charge control showed no significant effect on either growth or virulence, and the scrambled peptide a greatly reduced effect (Figure 1d ), suggesting a highly specific response to DYN.
Photoaffinity profiling of dynorphin targets
Intrigued by this phenotype, we next sought to identify protein interacting partners of DYN in live bacteria using photoprobes. Photoaffinity labelling is a technique used to explore small molecule-protein binding. 11, 12 A chemical probe mimicking the molecule of interest is equipped with a photoreactive group and a label or tag for detection. The probe is incubated with lysates or live cells, and, upon UV irradiation, a highly reactive intermediate is generated from the photoreactive group which crosslinks the probe to its biomolecular binding partners ( Figure   2a ). Common photoreactive groups include benzophenone (Bpa), aryl azides (ArN3) and diazirines (Di) (Figure 2b ), which possess different photo-properties and steric footprints. 13 Given their distinct and complementary properties, it is difficult to predict which photogroup will perform best in any one system; we therefore investigated all three. Rather than modify the peptide with a large label for detection, we incorporated a terminal alkyne into the structure of probes; this pre-tag allows subsequent attachment of a fluorophore or biotin affinity label via copper-catalysed azide-alkyne cycloaddition (CuAAC) for enrichment and visualization We initially focused on the Bpa probe DYN1, since probes with this photogroup gave the strongest labelling and high pyocyanin induction in PA. Proteins were subject to CuAAC with biotin-azide, enriched on avidin beads and digested. Peptides from control (DMSO vehicle treated) or DYN1 samples were isotopically dimethyl labelled16 for quantification, mixed and analyzed by gel-free LC-MS/MS. Consistent with the high level of labelling observed on-gel, large numbers of proteins were apparently enriched in DYN1 over control samples, suggestive of high non-specific binding or photoreactivity ( Figure S3 ). [17] [18] [19] We next performed chemical proteomic analyses with DYN4 and using a similar workflow but label-free MS1 intensity-based quantification (MaxLFQ), 20 which enables comparison across more samples. We included a competition experiment where bacteria were first incubated with 5-fold excess DYN and then with DYN4, with the aim of differentiating between genuine DYN binders over high abundance or false positive hits. DYN4 was more specific than DYN1 but still gave a large number of potential hits ( Figure S3 , Table S1 ). Outer membrane proteins (OMPs) figured prominently and biochemical separation of inner and outer membranes supported this result ( Figure S4 ). We also observed a surprising enrichment of ribosomal proteins (Table S1 ). To check for effects of DYN on protein synthesis, we treated early logphase bacteria with DYN at 10 µM for 2 hours and then incubated aliquots for 30 min with the methionine analogue azidohomoalanine (AHA), which is incorporated into newly synthesized proteins. 21, 22 Although total protein yield was lower for the DYN-treated bacteria due to reduction in growth, the rate of protein synthesis as measured by pulsed incorporation of AHA was the same ( Figure S4 ). Furthermore, a simple aryl azide 'minimal' probe 19 labelled proteins in the soluble fraction in a similar pattern to DYN4 ( Figure S4 ). Together these data suggest that aryl azide probes exhibit a high degree of non-specific binding in this system. Lack of LPS label-ling by DYN4 ( Figure S4 ) also suggested that this probe is biased in its reactivity. This may be related to the propensity of aryl azides to undergo ring expansion upon irradiation. 13 Finally, to investigate the protein targets of diazirine probe DYN5, bacteria were incubated with DYN at varying concentrations followed by DYN5 (ratios of 1:1, 1:2 and 1:5 of DYN5:DYN)
to generate competition data. Enrichment and label-free proteomics were carried out as before. Analysis of the data revealed more selective labelling compared to DYN1 and DYN4 (Figure 4a ), as expected given the lower intensity of in-gel labelling. A subset of enriched proteins was significantly outcompeted at 5-fold excess DYN ( Figure S5 ) and three proteins were also outcompeted at 2-fold excess DYN (Figure 4b ; Table S2 ). Of these, the protein ParS was alone in being completely absent from DMSO controls. ParS was also detected in DYN4
labelling, although only quantified in two out of three replicates. We analyzed the competition response profiles (LFQ intensity, raw intensity and sequence coverage) of all possible hits ( Figure S5 ; Figure 4c) ; ParS showed the most pronounced dose-dependent response.
ParS is a putative membrane sensor kinase and is predicted to be co-expressed with response regulator ParR in a two-component system. 23 The ParRS system has been linked to the response of PA to cationic antimicrobial peptides (AMPs). 24 AMPs include endogenous host peptides involved in the immune defense against infection and synthetic compounds in clinical use. Although in many cases their mode of action is unclear, AMPs often bind to the bacterial membrane and rapidly kill cells through formation of pores or membrane disruption. 25 Select peptides appear to act via ParRS to induce adaptive resistance to other AMPs -a response where the bacterial cell activates specific mechanisms that render it temporarily more resistant to attack. 24 Although DYN only slightly reduced growth (Figure 1c) , it is cationic. Thus we selected ParS out of the list of possible hits (Figure 4d ) as the most promising protein for further analysis.
Total proteome analysis of DYN-treated Pseudo-monas reveals an antimicrobial peptide-like defense response
If DYN binds ParS to induce an AMP-like response in PA, changes in the expression of specific proteins and pathways should be detectable. We therefore undertook a global proteome analysis of bacteria treated with the peptide. Bacteria were grown for 16 hours in the presence of 10 µM DYN (a concentration resulting in a small drop in growth and a measurable increase in pyocyanin; Figure S6 ).
Cells were subsequently lysed, lysates normalized based on total protein amount and samples prepared for analysis using the FASP protocol (filter-aided sample preparation), which enables lysis of samples in buffers containing high detergent concentrations to maximize solubilization of membrane proteins. 26 Peptides were analyzed by LC-MS/MS and quantified by MaxLFQ. 20 Over 3000 proteins were quantified in at least three biological replicates, with high reproducibility (Pearson correlations of 0.96-0.99, Figure S6 ). We observed a specific response, with only 5.5% of proteins significantly affected by DYN treatment (t-test; Figure 5a and Table S3 ). Gene ontology analysis suggested that siderophore biosynthesis and transport, sulfur compound metabolism, localization and transport processes were overrepresented amongst downregulated proteins, indicating moderate changes in iron homeostasis and uptake ( Figure S7 ). Proteins upregulated by DYN treatment included those involved in lipid A biosynthesis and belong to the arn operon (ArnA, B, C, D and T; Figure 5 and Figure S8 ), which is upregulated in response to diverse AMPs. ArnT adds 4-aminoarabinose to lipid A phosphate groups, reducing the negative charge of the membrane and promoting resistance to AMPs. 15 The arn operon is under the control of various twocomponent systems in PA, including ParRS, PmrAB and CprRS. 24,27,28 pmrA & pmrB are also upregulated by AMPs, 27 and expression levels of these two proteins increased strongly in response to DYN in our analysis.
Another highly upregulated protein with a known role in enhanced AMP resistance was SpeE2 (PA4774), 29 which, together with another upregulated product (PA4775), is predicted to be in the same operon as pmrAB. Another set of proteins that responded to DYN belong to the resistance-nodulation-division (RND) family and have known or putative roles in drug efflux.
These tripartite complexes consist of an RND transporter, a periplasmic membrane fusion protein and an outer membrane factor, and act to pump antibiotics across the cell membrane. 30, 31 All proteins from the mexGHI-opmD operon (PA4205-8) were significantly upregulated, as were MexX and MexY (PA2018-19; Table. S3 ). In contrast, the porin OprD, annotated as a basic amino acid, basic peptide and imipenem outer mem-brane transporter, was downregulated. Interestingly, the ParRS system has been previously linked to these changes.
32
Another virulence-related protein, PA-I galactophilic lectin (LecA) was strongly upregulated in our data. LecA is a cytotoxic lectin and adhesion molecule implicated in biofilm formation, 33 and induced in response to another host signal, interferon-. 8 The data described above were collected incubation of DYN throughout growth until stationary phase. To explore the effects of transient DYN exposure, bacteria were grown to early exponential phase and then incubated with a slightly lower concentration of 5 M DYN (to limit the mild inhibition of growth that DYN induces) and the global proteome analyzed (Table S4 ). Only 0.75% of proteins showed a significant response under these conditions: again, proteins in the arn and pmrAB operons were the most prominent upregulated hits (Figure 5b ). Thus, arn and pmrAB upregulation is a rapid, direct response to DYN under different growth stages.
In all analyses ParR and ParS proteins themselves were unaffected by DYN treatment;
however, this is not in-consistent with their role as mediators since a previous study by Fernández et al. reported that the AMP indolicidin had no effect on parRS expression, although this peptide triggered responses via parRS. We compared our dataset to the microarray transcriptome data of Fernández et al. 24 Proteins in the arn and pmr operons, significantly upregulated by DYN treatment in our analysis, were indeed induced by indolicidin treatment in wild-type relative to a parR mutant (Table S6) .
ParS mediates the DYN-induced phenotype
We hypothesized that of the possible DYN targets (Figure 4d ), ParS was most likely responsible for the AMP-defense phenotype. To test this hypothesis more directly, a PAO1 parS transposon mutant was obtained (PA Two-Allele Library, University of Washington), validated by PCR ( Figure S9 ) and assayed for response to DYN. Both this and a parR mutant were dramatically more susceptible to DYN-induced toxicity than the original wild-type (wt) strain and we did not observe any pyocyanin production in response to the peptide at nontoxic concentrations ( Figure S9 ). Using a low DYN concentration of 1 M to minimize effects on growth, we repeated the global proteome analysis of the parS mutant or wt PA treated with DYN for 16 hours ( Figure S6 ; Table S5 ). Even at this low concentration, there was strong upregulation of Arn proteins and PmrA & B in wt bacteria, whilst cells lacking ParS showed no significant response at all (Figure 6b ). Although there are differences between the parS mutant and wt strain proteomes, most proteins altered by DYN treatment in the wt were expressed at comparable levels ( Figure S10 ). Furthermore, although parR and parS mutants were more susceptible to DYN treatment (Figure 6b ), other strains from the library, such as a strain mutant in the unrelated response regulator phoP, showed a similar growth and phenotypic response to the wt ( Figure S9 ). Together these data strongly link ParS to the AMP-defense response of Pseudomonas to DYN.
Discussion
Here we use chemical probes to identify a membrane sensor kinase, ParS, as a binding partner of the human peptide dynorphin and the mediator of a highly specific bacterial defense response.
Dynorphin (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and the shorter (1-13) analogue (DYN) both induced production of the virulence factor pyocyanin. Interestingly this phenotype was highly medium-dependent, indicating that PA integrates multiple environmental signals in its response to these compounds. Pyocyanin induction was also peptide sequence-dependent; however, binding of DYN-based photoaffinity probes to the LPS was subsequently shown to be sequenceindependent, suggesting that LPS interaction is not responsible for induction of virulence but may be important for initial charge-mediated coordination with the cell membrane.
Photoaffinity probes with different photoreactive groups exhibited very distinct profiles, and the lack of specificity exhibited by both benzophenones and aryl azides, as noted recently by us and others, 17, 19 led us to focus on diazirine-containing probes. We identified the membrane protein ParS, the sensing partner of a two-component response system, as a promising hit.
Subsequent in-depth global proteome analyses of bacteria treated with DYN at different growth stages revealed a highly specific, parS-dependent, response: a dramatic increase in the levels of proteins that boost membrane defense mechanisms against cationic peptides.
Upregulated proteins included those in the arn operon that modify lipid A, reducing the negative charge of the membrane and thereby increasing AMP resistance. Such modifications also alter outer membrane permeability and host immune recognition of LPS, and are common in clinical isolates of PA from cystic fibrosis patients. 34 These data are consistent with previous reports of parRS-dependent arn upregulation and adaptive AMP resistance. 24 Previous work
showed that ParRS and a second two-component system CprRS mediate the response to diverse AMPs in PA in a peptide-dependent manner. 28 CprRS was not detected in our analyses, suggesting that it is not involved in DYN-dependent signaling. Interestingly, DYN is only weakly toxic but induces strong up-regulation of defense pathways, consistent with previous data indicating that the signaling and growth inhibition functions of AMPs are not directly coupled. 24, 27, 28 More work is needed to understand the structure-activity relationships of AMP signaling and the exact binding site of the peptides, but it is tempting to speculate that DYN binds at the predicted negatively charged periplasmic loops of ParS, in a similar manner to peptide binding to sensor PhoQ in Salmonella. 35 The mechanism of mild bacterial growth inhibition by DYN also remains to be explored, but may be due to stress induced by membrane binding.
Treatment of PA with Dyn-A has been previously linked to the PQS (Pseudomonas Quinolone Signal) quorum sensing (QS) system.4 AMPs, such as colistin, also induce expression of QS genes, 36 and ParRS has been linked to modest changes in quorum sensing pathways in PA. 37 However, we observed no upregulation of any QS proteins in our proteomic analyses. This could be due to the timing of analysis, or differences in the culture medium, which is a key determinate in the phenotypic response. Our proteomic data also do not readily explain the in-crease in pyocyanin production observed in response to DYN; of all the proteins involved in the synthesis of this toxin, only PhzB2 was upregulated. Again, this could reflect timing of analysis. How ParRS signaling may be linked to the circuitry for enhanced pyocyanin production is unclear, and it is possible that other sensors and pathways are involved in this aspect of the response. The other chemical proteomics hits identified here (Figure 4d ; e.g.
putative sensor/response regulator PA1243) are interesting starting points for further study.
We also observed DYN-induced upregulation of drug efflux pumps. A previous study showed that, unlike wt bacteria, a parRS mutant did not upregulate MexXY and downregulate the porin OprD in response to AMPs, and that spontaneous mutants in parR & S had heightened intrinsic resistance to diverse antibiotics. 32 This may be clinically relevant since the AMP colistin and other antibiotics are given sequentially to cystic fibrosis patients. 32, 38 The present study thus adds to the increasing body of evidence linking virulence and antibiotic resistance in Pseudomonas, and suggests that host factors can trigger a multi-resistant phenotype in this pathogen.
Conclusion
In summary, we reveal that a human opioid peptide induces a specific defense mechanism in P. aeruginosa via direct binding of the sensor ParS. We provide strong evidence that the 
